Diabetes and Endocrinology
Home Diabetes and Endocrinology
ADA, EASD Issue New Recommendations for T2DM
Additional focus on lifestyle management, self-management education and support emphasized
Aetna-CVS Merger Approved
Under the approval, Aetna must sell off its private Medicare drug plans
Intensive BP Therapy in Diabetes May Lower Risk for CV Events
Findings based on data reweighted to reflect the adult population with diabetes in the U.S.
Minority Residents Experience Burdens Linked to Race/Ethnicity
Residents describe daily barrage of microaggression, bias; being tasked as race/ethnicity ambassadors
Lorcaserin Beneficial for Diabetes in Overweight, Obese
Lorcaserin reduces risk for diabetes for those with prediabetes, without diabetes; reduces HbA1c
Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria
Best Practices for Congenital Adrenal Hyperplasia Updated
Recommendations address screening, treatment approaches and emphasize shared decision making
Industry-Funded Trials Often Involve Employees in Studies
Many trials published in high-impact journals involve funder, academic author in study design, reporting
Albiglutide Beats Placebo for Cardiovascular Events in T2DM
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Tips Provided for Budgeting in Medical Residency
Medical residents should understand their income, create a budget and stick to it, save for the future
